Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/13/2012 | CN101389221B Silver/water, silver gels and silver-based compositions, method for fabricating and using the same |
06/13/2012 | CN101386617B Substituted tetrahydroisoquinoline derivatives, preparation method thereof and pharmaceutical compositions containing same |
06/13/2012 | CN101357141B Water-soluble mixing active pearl calcium and preparation method thereof |
06/13/2012 | CN101356172B Kinase inhibitors |
06/13/2012 | CN101352432B Technique of preparing nano vitamin E emulsion |
06/13/2012 | CN101333166B New depside compounds, preparation method thereof and use |
06/13/2012 | CN101331146B Analogs of alpha galactosylceramide and uses thereof |
06/13/2012 | CN101312977B Fused heterocyclic compounds useful as kinase modulators |
06/13/2012 | CN101282723B Use of a compound and pharmaceutical composition comprising same |
06/13/2012 | CN101220068B A set of geldanamycin derivant and method for preparing the same |
06/13/2012 | CN101215303B Xylosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
06/13/2012 | CN101208334B Novel cyclic amines |
06/13/2012 | CN101200468B Novel compounds and uses thereof |
06/13/2012 | CN101198610B Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein |
06/13/2012 | CN101193682B Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
06/13/2012 | CN101094827B Benzene compound having two or more substituents |
06/13/2012 | CN101087590B Solid dosage form comprising proton pump inhibitor and suspension made thereof |
06/13/2012 | CN101014598B Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
06/12/2012 | WO2012082942A2 Neuropeptide analogs, compositions, and methods for treating pain |
06/12/2012 | US8200327 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
06/12/2012 | US8198483 Phenethanolamine derivatives for treatment of respiratory diseases |
06/12/2012 | US8198470 Crystalline form II of tigecycline and processes for preparation thereof |
06/12/2012 | US8198469 Crystalline forms of tigecycline and processes for preparation thereof |
06/12/2012 | US8198458 Non-nucleoside reverse transcriptase inhibitors |
06/12/2012 | US8198454 Amide derivatives and medicinal use thereof |
06/12/2012 | US8198453 Piperidine renin inhibitors |
06/12/2012 | US8198452 Polymorphic forms and process |
06/12/2012 | US8198450 Quinolinone derivatives and their pharmaceutical compositions |
06/12/2012 | US8198449 Compounds for the treatment of hepatitis C |
06/12/2012 | US8198448 Fused heterocyclic derivatives and methods of use |
06/12/2012 | US8198440 Phosphonic acid compounds as inhibitors of serine proteases |
06/12/2012 | US8198438 Pyrrolotriazine kinase inhibitors |
06/12/2012 | US8198435 Crystal form of N-benzoyl-staurosporine |
06/12/2012 | US8198430 Immunogenic sequences |
06/12/2012 | US8198427 SiRNA targeting catenin, beta-1 (CTNNB1) |
06/12/2012 | US8198420 Synthetic compounds useful as nodulation agents of leguminous plants and preparation processes thereof |
06/12/2012 | US8198419 Glycorandomization and production of novel erythromycin analogs |
06/12/2012 | US8198334 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
06/12/2012 | US8198333 Cytostatic drug composition |
06/12/2012 | US8198332 Salicylamide derivatives as nicotinic alpha 7 modulators |
06/12/2012 | US8198331 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
06/12/2012 | US8198330 Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
06/12/2012 | US8198329 Memory consolidation promoting agent and method of use |
06/12/2012 | US8198328 Treatment of cancer using benzoic acid derivatives |
06/12/2012 | US8198327 Fatty acid amides and uses thereof |
06/12/2012 | US8198326 Phenolic antiseptic compositions and methods of use |
06/12/2012 | US8198325 Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use |
06/12/2012 | US8198324 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
06/12/2012 | US8198323 Curcumin analogues and uses thereof |
06/12/2012 | US8198322 Apoptotic and anti-tumor activities of metallo-salens |
06/12/2012 | US8198321 Anti-microorganism terpenic composition |
06/12/2012 | US8198320 Hypoglycemic activity of osthole |
06/12/2012 | US8198319 Composition and method for treating diabetes and metabolic disorders |
06/12/2012 | US8198318 Therapeutic amides |
06/12/2012 | US8198317 Methylenedioxy phenolic compounds and their use to treat disease |
06/12/2012 | US8198316 Process for the preparation of 5,6 -dihydro -4H-4(S)-ethylamino-6(S)-methylthieno[2,3-b] thiopyran-2-sulfonamide- 7,7 -dioxide and its salt |
06/12/2012 | US8198315 Therapeutic substituted cyclic lactams |
06/12/2012 | US8198314 Treatment of CRTH2-mediated diseases and conditions |
06/12/2012 | US8198313 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
06/12/2012 | US8198312 Compositions and methods of making a photoactive agent |
06/12/2012 | US8198311 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
06/12/2012 | US8198310 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
06/12/2012 | US8198309 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides |
06/12/2012 | US8198308 Chemical compounds |
06/12/2012 | US8198307 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same |
06/12/2012 | US8198306 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor |
06/12/2012 | US8198305 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent |
06/12/2012 | US8198304 Guanidine-containing compounds useful as muscarinic receptor antagonists |
06/12/2012 | US8198303 Methods of use and compositions for the diagnosis and treatment of infectious diseases |
06/12/2012 | US8198302 Anticancer agent having a quinone, quinone prodrug, catechol or catechol prodrug moiety; free of combretastatin A-1 |
06/12/2012 | US8198301 Quinazoline and quinoline derivatives as irreversibe protein tyrosine kinase inhibitors |
06/12/2012 | US8198300 Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound |
06/12/2012 | US8198299 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
06/12/2012 | US8198298 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors |
06/12/2012 | US8198296 Sub-type selective azabicycloalkane derivatives |
06/12/2012 | US8198295 Benzonaphthyridines |
06/12/2012 | US8198294 Treatment of dyskinesia |
06/12/2012 | US8198293 Oxymatrine compositions and related methods for treating and preventing chronic infectious diseases |
06/12/2012 | US8198292 Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof |
06/12/2012 | US8198291 Intranasal opioid compositions |
06/12/2012 | US8198290 Methoxatin derivatives |
06/12/2012 | US8198289 Crystal form H imatinib mesylate for pharmaceutical use |
06/12/2012 | US8198288 Tetrahydropyrrolopyrimidinediones and their use in therapy |
06/12/2012 | US8198287 Substituted heteroaryl pyridopyrimidone derivatives |
06/12/2012 | US8198286 Sodium channel blockers |
06/12/2012 | US8198285 Pyrazine derivatives |
06/12/2012 | US8198284 Treatment of neurodegenerative disorders with thiourea compounds |
06/12/2012 | US8198283 Cysteine protease inhibitors |
06/12/2012 | US8198282 Substituted azaquinazolines having an antiviral action |
06/12/2012 | US8198281 Crystalline forms of dihydropyrazolopyrimidinone |
06/12/2012 | US8198280 N-hydroxyamide derivatives and use thereof |
06/12/2012 | US8198279 Pyrido[2,3-b]pyrazin-8-substituted compounds and their use |
06/12/2012 | US8198278 Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
06/12/2012 | US8198277 L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
06/12/2012 | US8198276 Kinase inhibitor compounds |
06/12/2012 | US8198275 Adamantyl diamide derivatives and uses of same |
06/12/2012 | US8198274 Substituted indolyl and indazolyl derivatives and uses thereof |
06/12/2012 | US8198273 Compounds and methods for kinase modulation, and indications therefor |
06/12/2012 | US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments |
06/12/2012 | US8198271 Thiophenediamine derivative having urea structure |